In the present study, we blocked CTLA-4 on the surface of both CLL cells and normal B lymphocytes to investigate the impact of CTLA-4 on the expression of the mentioned G1 phase regulators. The gene discussed is CTLA4; the disease is B-cell chronic lymphocytic leukemia.